Alexander Bagaev

Alexander Bagaev

Auto-generated profile, based on publicly available information

Alexander Bagaev

BostonGene Corporation, Waltham, Massachusetts

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Cancer Cell
Verified
Journal Article
Closed access
ABAlexander Bagaev
Alexander Bagaev
Nikita KotlovNikita Kotlov
Nikita Kotlov
KNKrystle Nomie
Krystle Nomie
VSViktor Svekolkin
Viktor Svekolkin
AGAzamat Gafurov
Azamat Gafurov
NFNathan Fowler
Nathan Fowler

1 April 2020 in Cancer Cell
Verified
Journal Article
Closed access
GWGeorge W. Wright
George W. Wright
DHDa Wei Huang
Da Wei Huang
JPJames D. Phelan
James D. Phelan
ZCZana A. Coulibaly
Zana A. Coulibaly
SRSandrine Roulland
Sandrine Roulland
LSLouis M. Staudt
Louis M. Staudt

4 February 2021 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
Nikita KotlovNikita Kotlov
Nikita Kotlov
ABAlexander Bagaev
Alexander Bagaev
MRMaria V. Revuelta
Maria V. Revuelta
JPJude Phillip
Jude Phillip
MCMaria Teresa Cacciapuoti
Maria Teresa Cacciapuoti
LCLeandro Cerchietti
Leandro Cerchietti
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. Transcriptomic and genetic characterization of DLBCL has increased the understanding of its intrinsic pathogenesis and provided potential therapeutic targets. However, the role of the microenvironment in DLBCL biology remains less understood. Here, we performed a transcriptomic analysis of the microenvironment of 4,655 DLBCLs from multiple independent cohorts and described four major lymphoma microenvironment categories that associate with distinct biological aberrations and clinical behavior. We also found evidence of genetic and epigenetic mechanisms deployed by cancer cells to evade microenvironmental constraints of lymphoma growth, supporting the rationale for implementing DNA hypomethylating agents in selected patients with DLBCL. In addition, our work uncovered new therapeutic vulnerabilities in the biochemical composition of the extracellular matrix that were exploited to decrease DLBCL proliferation in preclinical models. This novel classification provides a road map for the biological characterization and therapeutic exploitation of the DLBCL microenvironment.Significance: In a translational relevant transcriptomic-based classification, we characterized the microenvironment as a critical component of the B-cell lymphoma biology and associated it with the DLBCL clinical behavior establishing a novel opportunity for targeting therapies.This article is highlighted in the In This Issue feature, p. 1307

10 June 2022 in Blood Cancer Discovery
Verified
Journal Article
Open access
PDF file
GHGuangchun Han
Guangchun Han
QDQing Deng
Qing Deng
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
EDEnyu Dai
Enyu Dai
MDMinghao Dang
Minghao Dang
Michael GreenMichael Green
Michael Green
Follicular lymphoma (FL) is a B-cell malignancy with a complex tumor microenvironment that is rich in nonmalignant immune cells. We applied single-cell RNA sequencing to characterize the diverse tumor and immune cell populations of FL and identified major phenotypic subsets of FL T cells, including a cytotoxic CD4 T-cell population. We characterized four major FL subtypes with differential representation or relative depletion of distinct T-cell subsets. By integrating exome sequencing, we observed that somatic mutations are associated with, but not definitive for, reduced MHC expression on FL cells. In turn, expression of MHCII genes by FL cells was associated with significant differences in the proportions and targetable immunophenotypic characteristics of T cells. This provides a classification framework of the FL microenvironment in association with FL genotypes and MHC expression, and informs different potential immunotherapeutic strategies based upon tumor cell MHCII expression. Significance: We have characterized the FL-infiltrating T cells, identified cytotoxic CD4 T cells as an important component that is associated with tumor cell–intrinsic characteristics, and identified sets of targetable immune checkpoints on T cells that differed from FLs with normal versus low MHC expression. See related commentary by Melnick, p. 374. This article is highlighted in the In This Issue feature, p. 369

14 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAlexander V. Bagaev
Alexander V. Bagaev
AGAnastasiya Y. Garaeva
Anastasiya Y. Garaeva
ELEkaterina S. Lebedeva
Ekaterina S. Lebedeva
APAlexey V. Pichugin
Alexey V. Pichugin
RARavshan I. Ataullakhanov
Ravshan I. Ataullakhanov
Fazoil I. AtaullakhanovFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov
Signaling via Toll-like receptor 4 (TLR4) in macrophages constitutes an essential part of the innate immune response to bacterial infections. Detailed and quantified descriptions of TLR4 signal transduction would help to understand and exploit the first-line response of innate immune defense. To date, most mathematical modelling studies were performed on transformed cell lines. However, properties of primary macrophages differ significantly. We therefore studied TLR4-dependent activation of NF-κB transcription factor in bone marrow-derived and peritoneal primary macrophages. We demonstrate that the kinetics of NF-κB phosphorylation and nuclear translocation induced by a wide range of bacterial lipopolysaccharide (LPS) concentrations in primary macrophages is much faster than previously reported for macrophage cell lines. We used a comprehensive combination of experiments and mathematical modeling to understand the mechanisms of this rapid response. We found that elevated basal NF-κB in the nuclei of primary macrophages is a mechanism increasing native macrophage sensitivity and response speed to the infection. Such pre-activated state of macrophages accelerates the NF-κB translocation kinetics in response to low agonist concentrations. These findings enabled us to refine and construct a new model combining both NF-κB phosphorylation and translocation processes and predict the existence of a negative feedback loop inactivating phosphorylated NF-κB.

28 December 2023 in Blood
Verified
Journal Article
Closed access
PDF file
ASAleksandr Sarachakov
Aleksandr Sarachakov
AVArina Varlamova
Arina Varlamova
VSViktor Svekolkin
Viktor Svekolkin
MPMargarita Polyakova
Margarita Polyakova
IVItzel Valencia
Itzel Valencia
SPSanjay Patel
Sanjay Patel
The spatial anatomy of hematopoiesis in the bone marrow (BM) has been extensively studied in mice and other preclinical models, but technical challenges have precluded a commensurate exploration in humans. Institutional pathology archives contain thousands of paraffinized BM core biopsy tissue specimens, providing a rich resource for studying the intact human BM topography in a variety of physiologic states. Thus, we developed an end-to-end pipeline involving multiparameter whole tissue staining, in situ imaging at single-cell resolution, and artificial intelligence–based digital whole slide image analysis and then applied it to a cohort of disease-free samples to survey alterations in the hematopoietic topography associated with aging. Our data indicate heterogeneity in marrow adipose tissue (MAT) content within each age group and an inverse correlation between MAT content and proportions of early myeloid and erythroid precursors, irrespective of age. We identify consistent endosteal and perivascular positioning of hematopoietic stem and progenitor cells (HSPCs) with medullary localization of more differentiated elements and, importantly, uncover new evidence of aging-associated changes in cellular and vascular morphologies, microarchitectural alterations suggestive of foci with increased lymphocytes, and diminution of a potentially active megakaryocytic niche. Overall, our findings suggest that there is topographic remodeling of human hematopoiesis associated with aging. More generally, we demonstrate the potential to deeply unravel the spatial biology of normal and pathologic human BM states using intact archival tissue specimens.